Table of Content

1 Osteoarthritis Pain Medicine Market Overview
1.1 Product Overview and Scope of Osteoarthritis Pain Medicine
1.2 Osteoarthritis Pain Medicine Segment by Type
1.2.1 Global Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Pain Medicine Segment by Application
1.3.1 Global Osteoarthritis Pain Medicine Market Value by Application: (2024-2034)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Osteoarthritis Pain Medicine Market Size Estimates and Forecasts
1.4.1 Global Osteoarthritis Pain Medicine Revenue 2018-2034
1.4.2 Global Osteoarthritis Pain Medicine Sales 2018-2034
1.4.3 Global Osteoarthritis Pain Medicine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Osteoarthritis Pain Medicine Market Competition by Manufacturers
2.1 Global Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Osteoarthritis Pain Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Osteoarthritis Pain Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Osteoarthritis Pain Medicine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Osteoarthritis Pain Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Osteoarthritis Pain Medicine, Product Type & Application
2.7 Osteoarthritis Pain Medicine Market Competitive Situation and Trends
2.7.1 Osteoarthritis Pain Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Osteoarthritis Pain Medicine Players Market Share by Revenue
2.7.3 Global Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Osteoarthritis Pain Medicine Retrospective Market Scenario by Region
3.1 Global Osteoarthritis Pain Medicine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Osteoarthritis Pain Medicine Global Osteoarthritis Pain Medicine Sales by Region: 2018-2034
3.2.1 Global Osteoarthritis Pain Medicine Sales by Region: 2018-2023
3.2.2 Global Osteoarthritis Pain Medicine Sales by Region: 2024-2034
3.3 Global Osteoarthritis Pain Medicine Global Osteoarthritis Pain Medicine Revenue by Region: 2018-2034
3.3.1 Global Osteoarthritis Pain Medicine Revenue by Region: 2018-2023
3.3.2 Global Osteoarthritis Pain Medicine Revenue by Region: 2024-2034
3.4 North America Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.4.1 North America Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.4.3 North America Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.5.1 Europe Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.5.3 Europe Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.6.3 Asia Pacific Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.7.1 Latin America Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.7.3 Latin America Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Osteoarthritis Pain Medicine Sales by Type (2018-2034)
4.1.1 Global Osteoarthritis Pain Medicine Sales by Type (2018-2023)
4.1.2 Global Osteoarthritis Pain Medicine Sales by Type (2024-2034)
4.1.3 Global Osteoarthritis Pain Medicine Sales Market Share by Type (2018-2034)
4.2 Global Osteoarthritis Pain Medicine Revenue by Type (2018-2034)
4.2.1 Global Osteoarthritis Pain Medicine Revenue by Type (2018-2023)
4.2.2 Global Osteoarthritis Pain Medicine Revenue by Type (2024-2034)
4.2.3 Global Osteoarthritis Pain Medicine Revenue Market Share by Type (2018-2034)
4.3 Global Osteoarthritis Pain Medicine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Osteoarthritis Pain Medicine Sales by Application (2018-2034)
5.1.1 Global Osteoarthritis Pain Medicine Sales by Application (2018-2023)
5.1.2 Global Osteoarthritis Pain Medicine Sales by Application (2024-2034)
5.1.3 Global Osteoarthritis Pain Medicine Sales Market Share by Application (2018-2034)
5.2 Global Osteoarthritis Pain Medicine Revenue by Application (2018-2034)
5.2.1 Global Osteoarthritis Pain Medicine Revenue by Application (2018-2023)
5.2.2 Global Osteoarthritis Pain Medicine Revenue by Application (2024-2034)
5.2.3 Global Osteoarthritis Pain Medicine Revenue Market Share by Application (2018-2034)
5.3 Global Osteoarthritis Pain Medicine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Osteoarthritis Pain Medicine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson and Johnson Osteoarthritis Pain Medicine Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Osteoarthritis Pain Medicine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Osteoarthritis Pain Medicine Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly Osteoarthritis Pain Medicine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Osteoarthritis Pain Medicine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Osteoarthritis Pain Medicine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Horizon Pharma
6.8.1 Horizon Pharma Corporation Information
6.8.2 Horizon Pharma Description and Business Overview
6.8.3 Horizon Pharma Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Horizon Pharma Osteoarthritis Pain Medicine Product Portfolio
6.8.5 Horizon Pharma Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Corporation Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Osteoarthritis Pain Medicine Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Osteoarthritis Pain Medicine Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Corporation Information
6.11.2 Daiichi Sankyo Osteoarthritis Pain Medicine Description and Business Overview
6.11.3 Daiichi Sankyo Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Daiichi Sankyo Osteoarthritis Pain Medicine Product Portfolio
6.11.5 Daiichi Sankyo Recent Developments/Updates
6.12 TEVA
6.12.1 TEVA Corporation Information
6.12.2 TEVA Osteoarthritis Pain Medicine Description and Business Overview
6.12.3 TEVA Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 TEVA Osteoarthritis Pain Medicine Product Portfolio
6.12.5 TEVA Recent Developments/Updates
6.13 Almatica Pharma
6.13.1 Almatica Pharma Corporation Information
6.13.2 Almatica Pharma Osteoarthritis Pain Medicine Description and Business Overview
6.13.3 Almatica Pharma Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Almatica Pharma Osteoarthritis Pain Medicine Product Portfolio
6.13.5 Almatica Pharma Recent Developments/Updates
6.14 Astellas Pharma
6.14.1 Astellas Pharma Corporation Information
6.14.2 Astellas Pharma Osteoarthritis Pain Medicine Description and Business Overview
6.14.3 Astellas Pharma Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Astellas Pharma Osteoarthritis Pain Medicine Product Portfolio
6.14.5 Astellas Pharma Recent Developments/Updates
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Corporation Information
6.15.2 Tide Pharmaceutical Osteoarthritis Pain Medicine Description and Business Overview
6.15.3 Tide Pharmaceutical Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tide Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio
6.15.5 Tide Pharmaceutical Recent Developments/Updates
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Corporation Information
6.16.2 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Description and Business Overview
6.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Portfolio
6.16.5 Iroko Pharmaceuticals Recent Developments/Updates
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Corporation Information
6.17.2 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Description and Business Overview
6.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio
6.17.5 Hengrui Pharmaceutical Recent Developments/Updates
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Corporation Information
6.18.2 Abiogen Pharma Osteoarthritis Pain Medicine Description and Business Overview
6.18.3 Abiogen Pharma Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Abiogen Pharma Osteoarthritis Pain Medicine Product Portfolio
6.18.5 Abiogen Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Osteoarthritis Pain Medicine Industry Chain Analysis
7.2 Osteoarthritis Pain Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Osteoarthritis Pain Medicine Production Mode & Process
7.4 Osteoarthritis Pain Medicine Sales and Marketing
7.4.1 Osteoarthritis Pain Medicine Sales Channels
7.4.2 Osteoarthritis Pain Medicine Distributors
7.5 Osteoarthritis Pain Medicine Customers
8 Osteoarthritis Pain Medicine Market Dynamics
8.1 Osteoarthritis Pain Medicine Industry Trends
8.2 Osteoarthritis Pain Medicine Market Drivers
8.3 Osteoarthritis Pain Medicine Market Challenges
8.4 Osteoarthritis Pain Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Osteoarthritis Pain Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Osteoarthritis Pain Medicine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Osteoarthritis Pain Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Osteoarthritis Pain Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Osteoarthritis Pain Medicine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Osteoarthritis Pain Medicine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Osteoarthritis Pain Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Osteoarthritis Pain Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Osteoarthritis Pain Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Medicine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osteoarthritis Pain Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Osteoarthritis Pain Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Osteoarthritis Pain Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Osteoarthritis Pain Medicine Sales by Region (2024-2034) & (K Units)
Table 20. Global Osteoarthritis Pain Medicine Sales Market Share by Region (2024-2034)
Table 21. Global Osteoarthritis Pain Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Osteoarthritis Pain Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2024-2034)
Table 25. North America Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 28. North America Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Osteoarthritis Pain Medicine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Osteoarthritis Pain Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Osteoarthritis Pain Medicine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Osteoarthritis Pain Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Osteoarthritis Pain Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Osteoarthritis Pain Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Osteoarthritis Pain Medicine Sales (K Units) by Type (2024-2034)
Table 52. Global Osteoarthritis Pain Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Osteoarthritis Pain Medicine Sales Market Share by Type (2024-2034)
Table 54. Global Osteoarthritis Pain Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Osteoarthritis Pain Medicine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Osteoarthritis Pain Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Osteoarthritis Pain Medicine Revenue Market Share by Type (2024-2034)
Table 58. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Osteoarthritis Pain Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Osteoarthritis Pain Medicine Sales (K Units) by Application (2024-2034)
Table 62. Global Osteoarthritis Pain Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Osteoarthritis Pain Medicine Sales Market Share by Application (2024-2034)
Table 64. Global Osteoarthritis Pain Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Osteoarthritis Pain Medicine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Osteoarthritis Pain Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Osteoarthritis Pain Medicine Revenue Market Share by Application (2024-2034)
Table 68. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Osteoarthritis Pain Medicine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Business Overview
Table 77. Johnson and Johnson Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Johnson and Johnson Osteoarthritis Pain Medicine Product
Table 79. Johnson and Johnson Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Osteoarthritis Pain Medicine Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Osteoarthritis Pain Medicine Product
Table 89. Bayer Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly Osteoarthritis Pain Medicine Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Osteoarthritis Pain Medicine Product
Table 99. Novartis Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Osteoarthritis Pain Medicine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Horizon Pharma Corporation Information
Table 106. Horizon Pharma Description and Business Overview
Table 107. Horizon Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Horizon Pharma Osteoarthritis Pain Medicine Product
Table 109. Horizon Pharma Recent Developments/Updates
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Osteoarthritis Pain Medicine Product
Table 114. Abbott Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Mylan Osteoarthritis Pain Medicine Product
Table 119. Mylan Recent Developments/Updates
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Business Overview
Table 122. Daiichi Sankyo Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Daiichi Sankyo Osteoarthritis Pain Medicine Product
Table 124. Daiichi Sankyo Recent Developments/Updates
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Business Overview
Table 127. TEVA Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. TEVA Osteoarthritis Pain Medicine Product
Table 129. TEVA Recent Developments/Updates
Table 130. Almatica Pharma Corporation Information
Table 131. Almatica Pharma Description and Business Overview
Table 132. Almatica Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Almatica Pharma Osteoarthritis Pain Medicine Product
Table 134. Almatica Pharma Recent Developments/Updates
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Business Overview
Table 137. Astellas Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Astellas Pharma Osteoarthritis Pain Medicine Product
Table 139. Astellas Pharma Recent Developments/Updates
Table 140. Tide Pharmaceutical Corporation Information
Table 141. Tide Pharmaceutical Description and Business Overview
Table 142. Tide Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Tide Pharmaceutical Osteoarthritis Pain Medicine Product
Table 144. Tide Pharmaceutical Recent Developments/Updates
Table 145. Iroko Pharmaceuticals Corporation Information
Table 146. Iroko Pharmaceuticals Description and Business Overview
Table 147. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product
Table 149. Iroko Pharmaceuticals Recent Developments/Updates
Table 150. Hengrui Pharmaceutical Corporation Information
Table 151. Hengrui Pharmaceutical Description and Business Overview
Table 152. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product
Table 154. Hengrui Pharmaceutical Recent Developments/Updates
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Business Overview
Table 157. Abiogen Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Abiogen Pharma Osteoarthritis Pain Medicine Product
Table 159. Abiogen Pharma Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Osteoarthritis Pain Medicine Distributors List
Table 163. Osteoarthritis Pain Medicine Customers List
Table 164. Osteoarthritis Pain Medicine Market Trends
Table 165. Osteoarthritis Pain Medicine Market Drivers
Table 166. Osteoarthritis Pain Medicine Market Challenges
Table 167. Osteoarthritis Pain Medicine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Osteoarthritis Pain Medicine
Figure 2. Global Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Osteoarthritis Pain Medicine Market Share by Type in 2024 & 2034
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Osteoarthritis Pain Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Osteoarthritis Pain Medicine Market Share by Application in 2024 & 2034
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Global Osteoarthritis Pain Medicine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Osteoarthritis Pain Medicine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Osteoarthritis Pain Medicine Sales (2018-2034) & (K Units)
Figure 14. Global Osteoarthritis Pain Medicine Average Price (USD/Unit) & (2018-2034)
Figure 15. Osteoarthritis Pain Medicine Report Years Considered
Figure 16. Osteoarthritis Pain Medicine Sales Share by Manufacturers in 2024
Figure 17. Global Osteoarthritis Pain Medicine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Osteoarthritis Pain Medicine Players: Market Share by Revenue in 2024
Figure 19. Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Osteoarthritis Pain Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 22. North America Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 26. Europe Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Osteoarthritis Pain Medicine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Osteoarthritis Pain Medicine Revenue Market Share by Region (2018-2034)
Figure 34. China Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Osteoarthritis Pain Medicine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Osteoarthritis Pain Medicine by Type (2018-2034)
Figure 56. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Osteoarthritis Pain Medicine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Osteoarthritis Pain Medicine by Application (2018-2034)
Figure 59. Global Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2018-2034)
Figure 60. Osteoarthritis Pain Medicine Value Chain
Figure 61. Osteoarthritis Pain Medicine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed